当前位置:首页 - 行情中心 - 益方生物-U(688382) - 财务分析 - 现金流量表

益方生物-U

(688382)

  

流通市值:122.16亿  总市值:169.17亿
流通股本:4.18亿   总股本:5.78亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金18,233,258.8810,331,979.22-131,258,835.61
  收到的税费返还---8,090,016
  收到其他与经营活动有关的现金17,343,177.0713,383,947.862,477,134.2716,974,725.5
  经营活动现金流入小计35,576,435.9523,715,927.082,477,134.27156,323,577.11
  购买商品、接受劳务支付的现金99,269,898.8862,225,112.3631,665,686.44254,733,207.17
  支付给职工以及为职工支付的现金88,822,416.7163,887,002.7629,755,885.22130,740,357.35
  支付的各项税费329,926.72213,682.55120,816.7556,782.65
  支付其他与经营活动有关的现金7,210,577.574,640,029.772,959,698.5212,266,085.55
  经营活动现金流出小计195,632,819.88130,965,827.4464,502,086.88398,296,432.72
  经营活动产生的现金流量净额平衡项目00.0100
  经营活动产生的现金流量净额-160,056,383.93-107,249,900.35-62,024,952.61-241,972,855.61
二、投资活动产生的现金流量:
  收回投资收到的现金935,482,609.3210,000,000-700,000,000
  取得投资收益收到的现金14,913,198.362,084,099.81-21,153,504.26
  投资活动现金流入的平衡项目00-0
  投资活动现金流入小计950,395,807.66212,084,099.81-721,153,504.26
  购建固定资产、无形资产和其他长期资产支付的现金6,274,311.625,118,259.72,670,480.397,560,769.41
  投资支付的现金1,026,483,821.51500,318,140256,955,180767,521,382.7
  投资活动现金流出小计1,032,758,133.13505,436,399.7259,625,660.39775,082,152.11
  投资活动产生的现金流量净额-82,362,325.47-293,352,299.89-259,625,660.39-53,928,647.85
三、筹资活动产生的现金流量:
  吸收投资收到的现金6,974,337.66,884,523.156,884,523.157,591,598.25
  筹资活动现金流入小计6,974,337.66,884,523.156,884,523.157,591,598.25
  支付其他与筹资活动有关的现金5,843,945.243,695,841.81,336,656.214,072,917.05
  筹资活动现金流出小计5,843,945.243,695,841.81,336,656.214,072,917.05
  筹资活动产生的现金流量净额1,130,392.363,188,681.355,547,866.95-6,481,318.8
四、汇率变动对现金及现金等价物的影响-2,492,032.99-905,461.13-658,193.82503,717.88
  现金及现金等价物净增加额平衡项目0-0.0100
五、现金及现金等价物净增加额-243,780,350.03-398,318,980.03-316,760,939.87-301,879,104.38
  加:期初现金及现金等价物余额913,946,568.19913,946,568.19913,946,568.191,215,825,672.57
  期末现金及现金等价物余额670,166,218.16515,627,588.16597,185,628.32913,946,568.19
补充资料:
  净利润--119,432,479.85--240,203,844.86
  固定资产和投资性房地产折旧-2,482,027.05-5,466,177.63
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-2,482,027.05-5,466,177.63
  无形资产摊销-240,081.36-328,568.75
  长期待摊费用摊销-545,881.71-1,045,229.13
  处置固定资产、无形资产和其他长期资产的损失----75,015.44
  公允价值变动损失--886,746.71--1,300,000
  财务费用--3,980,199.96--22,787,909.89
  投资损失--84,099.81--
  递延所得税-0-0
  其中:递延所得税资产减少--14,556.84--538,868.07
    递延所得税负债增加-14,556.84-538,868.07
  经营性应收项目的减少--10,018,176.45-13,958,077.54
  经营性应付项目的增加--16,706,667.49--67,868,520.66
  其他-20,330,884.47-47,452,064.83
  现金的期末余额-515,627,588.16-913,946,568.19
  减:现金的期初余额-913,946,568.19-1,215,825,672.57
  现金及现金等价物的净增加额--398,318,980.03--301,879,104.38
公告日期2025-10-302025-08-232025-04-292025-04-26
审计意见(境内)标准无保留意见
TOP↑